Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7991 vs Cinacalcet in Secondary Hyperparathyroidism
NCT02133404Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Countries
- 1
01
Overview
A Phase 2 trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Astellas Pharma. Started Mar 2014; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02133404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133404.